Halo Neuroscience

About:

Halo Neuroscience is a neurotech company focused on using electrical neurostimulation to unlock human performance and treat human disease

Website: http://haloneuro.com/

Twitter/X: HaloNeuro

Top Investors: TPG, Kima Ventures, Future Planet Capital, Andreessen Horowitz, Global Brain Corporation

Description:

Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes. Neuropriming is the process of using electrical stimulation during movement-based training to build stronger, more optimized connections between your brain and muscles. This process induces a temporary state of hyper-learning or "hyperplasticity" in the brain, which refines the brain's ability to learn and adapt to training. The company was incorporated in 2013 and is based in San Francisco, CA.

Total Funding Amount:

$24.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)haloneuro.com

Founders:

Amol Sarva, Brett Wingeier, Daniel Chao, Lee von Kraus, PhD

Number of Employees:

11-50

Last Funding Date:

2018-04-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai